HOME >> BIOLOGY >> NEWS
At Berkeley: Intelligently designed molecular evolution

Evolutionary paths to new therapeutic drugs, as well as a wide assortment of other enzyme products, have been created through, of all things, intelligent design. A team of researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California at Berkeley have developed a technique in which the evolution of an important class of proteins is steered towards a desired outcome.

"We've taken enzymes that are promiscuous, meaning they have the capacity to evolve along many different functional lines, and trained them to become specialists," said chemical engineer Jay Keasling, who led this study.

"This technology could be used by pharmaceutical manufacturers in the future to create specific enzyme products."

Keasling is director of Berkeley Lab's Physical Biosciences Division, and a professor of chemical engineering with UC Berkeley's Chemical Engineering Department. Collaborating with him on this project were his graduate student, Yasuo Yoshikuni, and Thomas Ferrin, a professor of pharmaceutical chemistry and biopharmaceutical sciences at UC San Francisco.

The results of this study were reported in the February 22, 2006, on-line edition of the journal Nature.

According to the theory of divergent molecular evolution, primordial enzymes and other proteins started out as "promiscuous" so that primitive organisms would be better able to adapt to their environment. Driven by selective pressures, these promiscuous enzymes and other proteins evolved along divergent lines to acquire the specialized functions needed by a host organism to survive.

"This process is highly dependent on the fact that the functions of promiscuous proteins can be altered with just a small number of amino acid substitutions, a property known as plasticity," said Keasling. "It was our contention that the application of the theory of divergent molecular evolution to promiscuous enzymes would enable us to design enzym
'"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
23-Feb-2006


Page: 1 2 3

Related biology news :

1. Alzheimers drug based on Purdue -- designed inhibitor begins clinical trials
2. Computer-designed molecule to clean up fluorocarbons?
3. Georgia Tech computer program designed to halt pandemics installed in Georgia
4. Redesigned protein accelerates blood clotting
5. INEEL-designed system assists army with chemical weapon destruction
6. New textbook illuminates the close links between evolutionary and molecular biology
7. New molecular regulators of hyperthyroidism and goiter
8. A novel molecular dictator with a conscience discovered
9. UC Santa Barbara scientists clarify molecular basis of interferon action
10. MU researchers make discovery in molecular mechanics of phototropism
11. Malaria-resistant mosquitoes battle disease with molecular warhead

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... 2019 , ... An upcoming episode of Advancements with Ted ... helping to promote normal immune function in order to prevent and fight cancer. ... DECODE.DESIGN.CURE™ technology platform, which rapidly develops microbiome therapeutics in order to enable a ...
(Date:8/14/2019)... ... August 13, 2019 , ... Join Anguraj Sadanandam, PhD, Team ... Cancer Research (ICR) in a live webinar on Wednesday, September 4, ... and companion diagnostic development including machine learning approaches in different gastrointestinal cancers and ...
(Date:8/6/2019)... , ... August 05, 2019 , ... Keck Graduate Institute ... School of Pharmacy and Health Sciences (SPHS). , “Dean Zdanowicz is highly regarded as ... Trustees Chairman Jim Widergren. “He is a great choice to build on the success ...
Breaking Biology News(10 mins):
(Date:8/23/2019)... ... 22, 2019 , ... An upcoming episode of Advancements with ... 4Q/2019. Check your local listings for more information. , This segment will educate ... on therapeutics for children and the elderly, viewers will learn about Avro’s core ...
(Date:8/7/2019)... ... 07, 2019 , ... Locus Agricultural Solutions (Locus AG) reports record levels of ... including Rhizolizer ® , which is pulling up to 121% more carbon into ... to date. Results from the treatment of almonds, cherries, turf/sod, grapes and citrus across ...
(Date:8/4/2019)... ... 02, 2019 , ... Cirtec Medical Corporation, a strategic outsourcing partner for complex ... begun construction on a 30,000 sq. ft. manufacturing facility in the Coyol free ... The facility, which is expected to be fully operational by the end of the ...
(Date:7/19/2019)... ... July 18, 2019 , ... World renowned ... be joining forces with California-based charity Coalition Duchenne for its 9th Annual Expedition ... raises awareness and funding for Duchenne muscular dystrophy and was founded by Sabahan ...
Breaking Biology Technology:
Cached News: